Sign in

CIK 0001035354

  • Non-accelerated filer
  • Smaller reporting company

Eloxx Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELOX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841368850
Phone
+1 781-577-5300
Business address
P.O. BOX 274, ARLINGTON, MA, 02476
Former names
Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2014-05-16 SMIDER VAUGHN Chief Scientific Officer Grant or award · Warrants +267,862 267,862
2014-05-16 SMIDER VAUGHN Chief Scientific Officer Grant or award · Warrants +739 739
2014-05-16 SMIDER VAUGHN Chief Scientific Officer Grant or award · Warrants +13,394 13,394
2014-05-16 SMIDER VAUGHN Chief Scientific Officer Grant or award · Warrants +7,411 249,974
2014-05-16 SMIDER VAUGHN Chief Scientific Officer Grant or award · Warrants +244 8,180
2014-05-16 SMIDER VAUGHN Chief Scientific Officer Grant or award · Warrants +8,185 276,047
2014-05-16 SMIDER VAUGHN Chief Scientific Officer Grant or award · Warrants +23 762
2014-05-16 SMIDER VAUGHN Chief Scientific Officer Grant or award · Warrants +410 13,804

Page 20 of 20 · 388 trades